Skip To Main Content
Erik Ingmar Hallin on Muck Rack

Erik Ingmar Hallin

As seen in: British Pharmacological Society
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Erik Ingmar

Contact Erik Ingmar, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Pharmacokinetic-pharmacodynamic modelling in a clinical pilot study of rituximab in multiple sclerosis: Towards personalized dosing interval

|
By Trond Trætteberg Serkland, Silje Skrede, Kjell-Morten Myhr, Erik Ingmar Hallin
| British Pharmacological Society
SUPPLEMENTARY MATERIAL S1 LC–MS/MS method TABLE S1 Pharmacokinetic parameters Bensalem et al.29 TABLE S2 Tested pharmacokinetic models and their goodness of fit. TABLE S3 Individual estimates for PK model 3. TABLE S4 Individual estimates for PKPD model 3. TABLE S5 Estimated parameter values for the model by Pan et al.27 FIGURE S1 PK model in Bensalem et al.29 FIGURE S2 Individual model predictions and data for model 3. FIGURE S3 Observation–prediction plot for PK model 3.
Open in Who Shared Issue with article?
See all 1 articles